Page 10 - Hematology_ Basic Principles and Practice ( PDFDrive )

CONTRIBUTORS

Omar Abdel-Wahab, MD Aśok C. Antony, MD, MACP
Assistant Member in the Human Oncology and Pathogenesis Chancellor’s Professor of Medicine, Indiana University School of
Program, Attending Physician, Leukemia Service, Department of Medicine, Indianapolis, Indiana
Medicine, Memorial Sloan Kettering Cancer Center, New York, Megaloblastic Anemias
New York
Stem Cell Model of Hematologic Diseases David J. Araten, MD
Assistant Professor, New York University School of Medicine, New
Janet L. Abrahm, MD York VA Medical Center, Division of Hematology, Laura and Isaac
Professor of Medicine, Harvard Medical School; Division of Adult Perlmutter Cancer Center, New York University Langone Medical
Palliative Care, Department of Psychosocial Oncology and Palliative Center, New York, New York
Care, Dana-Farber Cancer Institute; Division of Palliative Medicine, Complement and Immunoglobulin Biology Leading to Clinical
Department of Medicine, Brigham and Women’s Hospital, Boston, Translation
Massachusetts
Palliative Care Philippe Armand, MD, PhD
Associate Professor of Medicine, Medical Oncology, Dana-Farber
Sharon Adams, MT, CHS (ABHI) Cancer Institute, Boston, Massachusetts
Supervisor, HLA Laboratory, Department of Transfusion Medicine, Immune Checkpoint Blockade in Hematologic Malignancies
NIH Clinical Center, Bethesda, Maryland
Human Leukocyte Antigen and Human Neutrophil Antigen Systems Gillian Armstrong, PhD
The EMMES Corporation, Rockville, Maryland
Adeboye H. Adewoye, MD Investigational New Drug–Enabling Processes for Cell-Based Therapies
Director, Clinical Research Hematology-Oncology, Gilead Sciences,
Inc, Foster City, California Scott A. Armstrong, MD, PhD
Pathobiology of the Human Erythrocyte and Its Hemoglobins Chairman, Department of Pediatric Oncology, Dana-Farber Cancer
Institute; Associate Chief, Division of Hematology/Oncology,
Carl Allen, MD, PhD Boston Children’s Hospital; David G. Nathan Professor of
Associate Professor of Pediatrics, Baylor College of Medicine, Pediatrics, Harvard Medical School, Boston, Massachusetts
Houston, Texas Pathobiology of Acute Lymphoblastic Leukemia
Infectious Mononucleosis and Other Epstein-Barr Virus-Associated
Diseases Donald M. Arnold, MD, MSc
Associate Professor of Medicine, Michael G. DeGroote School
Richard F. Ambinder, MD, PHD of Medicine, McMaster University; Associate Medical Director,
Professor of Oncology, Johns Hopkins School of Medicine, Canadian Blood Services, Hamilton, Ontario, Canada
Baltimore, Maryland Diseases of Platelet Number: Immune Thrombocytopenia, Neonatal
Virus-Associated Lymphomas Alloimmune Thrombocytopenia, and Posttransfusion Purpura
Claudio Anasetti, MD Andrew S. Artz, MD, MS
Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, Associate Professor of Medicine, Section of Hematology/Oncology,
Florida University of Chicago, Chicago, Illinois
Unrelated Donor Hematopoietic Cell Transplantation Hematology in Aging
John Anastasi, MD Farrukh T. Awan, MD, MS
Associate Professor, Department of Pathology, University of Associate Professor of Medicine, Division of Hematology, The Ohio
Chicago, Pritzker School of Medicine; Director, Secton of State University, Columbus, Ohio
Hematopathology, Clinical Hematology Laboratory, University of Chronic Lymphocytic Leukemia
Chicago Medical Center, Chicago, Illinois
The Pathologic Basis for the Classification of Non-Hodgkin and Trevor P. Baglin, MB, PhD
Hodgkin Lymphomas Consultant Hematologist, Hematology, Addenbrookes Hospital,
Cambridge University Teaching Hospitals, Cambridge, United
Julia A. Anderson, MBChB, MD Kingdom
Consultant Hematologist, Department of Clinical and Laboratory Regulatory Mechanisms in Hemostasis
Hematology, Royal Infirmary of Edinburgh, Edinburgh, Scotland;
Honorary Senior Lecturer, College of Medicine and Veterinary Don M. Benson, Jr., MD
Medicine, University of Edinburgh, Edinburgh, Scotland Associate Professor of Clinical Internal Medicine, Department
Hypercoagulable States of Internal Medicine, Division of Hematology, The Ohio State
University Comprehensive Cancer Center, Columbus, Ohio
Joseph H. Antin, MD Natural Killer Cell Immunity
Professor of Medicine, Harvard Medical School; Chief, Stem
Cell Transplantation, Dana-Farber Cancer Institute, Boston,
Massachusetts
Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid
Leukemia and Myelodysplastic Syndrome in Adults

vii